Scientist, principle investigator @sabanciu, studying SUMOylation in health and disease; @BrownUniversity, @MSKCancerCenter, @institutpasteur, @Inserm alum
Scientific publishing needs to change. In a new preprint, HHMI President Erin O'Shea and Bodo Stern argue that the incentives are misaligned. Researchers should be evaluated on what they choose to share, not what journals select. I’m proud that @hhmi_science is leading the way. Read the preprint here: https://t.co/CV1iiwgIvY
Talked to someone who failed to cite our preprint that showed an AlphaFold model with lots of experimental validation when he submitted cryo-EM paper of exact same sytem in Nature with no bio. data 6 months later. He said as a matter of policy "I don't cite preprints." Unethical.
Our new paper demonstrates for the first time the in vivo feasibility of PML-based therapeutic strategies for neurodegeneration. Focusing on ALS, we provide strong proof of concept evidence that inducing PML to clear disease-causing proteins is a promising therapeutic approach
Sadly, the rate publication inflation is likely to get worse!
The slicing of what should be a supplemental figure into entire separate papers, and then slicing again, and again is now standard practice
It threatens scientific quality and actually may slow real progress
Two business school professors from the University of Technology in Sydney have sounded the alarm on the declining quality of academic literature in a new publication titled “The junkification of research”.
Drawing parallels to the “enshittification” of online platforms, they argue that similar forces are now overwhelming scholarly publishing. The key drivers are threefold: 1) relentless “publish or perish” pressures in academia, 2) scientific publisher’s incentive to publish more to make more money, and 3) AI making paper production faster and easier. Taken together, they say, these drivers are a recipe for disaster. The authors call for a shift to not-for-profit models of scientific publishing and better evaluation systems.
I strongly doubt either is going to happen.
The problem is of course not new, and you all know that I have been drawing attention to this trend for more than a decade. It is interesting to see, however, that the awareness for the issue is increasing.
Paper: Rhodes, C., & Linnenluecke, M. K., “The junkification of research” Organization (2025).
New paper out ! In this Viewpoint article, I explore a bold and provocative idea: that Cas9, the catalytic engine of the CRISPR gene editing platform, may also possess a previously unrecognized effector-like role in eukaryotes during bacterial infection
https://t.co/IOewVaeFUK
Many thanks to @Eczacibasi group and Dr. Nejat F. Eczacıbaşı Foundation for this meaningful award, and for their vision and continued commitment to support life sciences in our country.
2025 Dr. Nejat F. Eczacıbaşı Tıp Ödülleri sahiplerini buldu.
Tıp Onur Ödülü Prof. Dr. Mehmet Şükrü Sever ve Tıp Bilim Ödülü Prof. Dr. Ali Koşar’a verilirken; Tıp Teşvik Ödülü Doç. Dr. Fatih İnci ve Doç. Dr. Şefik Evren Erdener, Bilimsel Araştırma Destek Ödülü Prof. Dr. Seda Kızılel, Hedeflendirilmiş Tedaviler Konulu Bilimsel Araştırma Destek Ödülü Doç. Dr. Umut Şahin ve Tıp Öğrencileri Proje Ödülü İsmail Emir Yassı’nın oldu.
2025 ödüllerini kazanan bilim insanlarını tıp alanındaki başarılı çalışmalarından ötürü bir kez daha kutluyoruz.
Nejat F. Eczacıbaşı Tıp Ödülleri’nden üçü, BAGEP Ödül sahibi Ali Koşar, Umut Şahin ve Fatih İnci’ye verildi.
2013’ten beri genç akademisyenlere araştırma desteği sağlayan Bilim Akademisi olarak araştırmacılarımızı kutluyoruz.
https://t.co/cp4HOOoi6l
I am honored to receive the @Eczacibasi Medicine Award in the Targeted Therapies category, joining an inspiring list of scientists and physicians recognized since the award's launch in 1959.
https://t.co/l9mgczP3PX
What is a PhD?
“It is an award to an expert who has proven their scientific worth and not to someone who stayed in a tolerant group for long enough.”
—
"Bu, bilimsel değerini kanıtlamış bir uzmana verilen bir ödüldür, hoşgörülü bir grupta uzun süre kalmış birine verilen bir ödül değildir.”